:::°æÈñ´ëÇб³ ÇÑÀǰú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
:::°æÈñ´ëÇб³ ÇÑÀǰú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
¡¡
¡¡
Total 204
¹øÈ£
Á¦¸ñ
±Û¾´ÀÌ
³¯Â¥
Á¶È¸
204
The Ameliorative Effect of Sophoricoside on Mast Cell-Mediat¡¦
ÃÖ°í°ü¸®ÀÚ
08-21
2002
203
Apoptosis induced by tanshinone IIA and cryptotanshinone is ¡¦
ÃÖ°í°ü¸®ÀÚ
08-21
1850
202
Embelin induces apoptosis in human glioma cells through inac¡¦
ÃÖ°í°ü¸®ÀÚ
08-21
1889
201
Protective effect of rosmarinic acid is through regulation o¡¦
ÃÖ°í°ü¸®ÀÚ
08-21
1708
200
Decursin and doxorubicin are in synergy for the induction of¡¦
ÃÖ°í°ü¸®ÀÚ
08-21
1780
199
Melatonin suppresses the expression of 45S pre-ribosomal RNA¡¦
ÃÖ°í°ü¸®ÀÚ
08-21
1724
198
Activation of AMP-activated protein kinase ¥á and extracellu¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
1846
197
Penta-O-galloyl-beta-D-glucose enhances antitumor activity o¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
1897
196
Ginkgetin induces apoptosis via activation of caspase and in¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
1803
195
Saengmaeksan inhibits inflammatory mediators by suppressing ¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
1910
194
Single Oral Dose Pharmacokinetics of Decursin, Decursinol An¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
2050
193
Activation of c-Jun N-Terminal Kinase Mediates Tanshinone II¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
1867
192
Matrix detachment and proteasomal inhibitors diminish Sulf-2¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
2033
191
Expression patterns of MDA-9/syntenin during development of ¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
2033
190
Effects of topical application of Astragalus membranaceus on¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
1998
1
2
3
4
5
6
7
8
9
10
Á¦¸ñ
³»¿ë
Á¦¸ñ+³»¿ë
ȸ¿ø¾ÆÀ̵ð
ȸ¿ø¾ÆÀ̵ð(ÄÚ)
À̸§
À̸§(ÄÚ)
and
or
:::°æÈñ´ëÇб³ ÇÑÀǰú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::